Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.
An algorithm based testing for Fatty Liver Disease
National Institute of Biologicals should undertake the testing of more biologicals and also extend its testing expertise in helping other countries
Analysis of Post-Marketing Safety Data Shows Consistent Findings with Safety Profile Reported in Clinical Trials of Edaravone
Safety in these pediatric populations was consistent with the known safety profile across approved adult and pediatric indications1,2
HIL has set up the Bti bio-larvicide manufacturing facility at its Rasayani Plant at Maharashtra with the financial assistance of GEF/UNIDO under the project
By applying digital technologies, pharma companies can significantly improve their operational and decision-making capabilities
Both vaccine candidates demonstrated a favorable safety and tolerability profile similar to the Pfizer-BioNTech COVID-19 Vaccine
V116 designed to target serotypes that account for 85% of all invasive pneumococcal disease in individuals aged 65 and over in the United States as of 2019
It is only the second healthcare provider in the world to attain the Stage 6 DIAM certification.
Subscribe To Our Newsletter & Stay Updated
